Rising Glucose Demand Pads Bottom Line Of Shengtai Pharmaceutical
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Shengtai Pharmaceutical's net profit for the fourth quarter of 2007 rose by 97 percent year-on-year to $3.1 million, as a result of robust sales of pharmaceutical-grade glucose products, Shengtai CFO Philips Zhang told investors during a second-quarter earnings call Feb. 15